Mertiva AB

About Us

Mertiva AB (former Diamyd Medical) primarily consists of holdings in liquid assets and holdings in Protein Sciences Corporation and Mercodia AB. Mertiva (former Diamyd Medical) shares are listed on Nasdaq OMX (segment Small Cap) in Stockholm (ticker: DIAM B) and on OTCQX in the US (ticker: DMYDY) administered by the Pink OTC Markets and the Bank of New York Mellon (PAL).

Pick a time period -

Tags ( Active)

All Regulatory Non-Regulatory

Financial Statement 10/11

Thu, Oct 13, 2011 08:30 CET

Year End Report, Stockholm, October 13, 2011September 1, 2010 – August 31, 2011 Fourth quarter report for Diamyd Medical AB (publ.), fiscal year 2010/2011(www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY)Fourth quarter, June 1, 2011 – August 31, 2011 · Group net sales for the fourth quarter were MSEK 2.2 (110.2) · Loss before tax for the fourth quarter was MSEK -26.5 (75.0) · Earnings per share after dilution for the fourth quarter were SEK -0.9 (2.6) · The Group’s liquid assets and short term investments amounted to MSEK 435.6 (501.3) as of August 31, 2011

Financial Statement 08/09

Fri, Oct 23, 2009 08:31 CET

Fourth Quarter Report, Stockholm, October 23, 2009 Fourth Quarter Report for Diamyd Medical AB (publ.), Fiscal Year 2008/2009 (www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY) Fourth quarter, June 1, 2009 – August 31, 2009• The US FDA approves the inclusion of children aged 10 and above in American Phase III study with the Diamyd® diabetes vaccine • The first children are vaccinated in a prevention study with Diamyd® with the aim of preventing type 1 diabetes • The Company begins to include children and accelerate patient recruitment for its American Phase III study with the

There are no items matching the current filter

There are no more items matching the current filter

Share

About Us

Financial Statement 10/11

Financial Statement 08/09

Media